NeonMind Financial Statements From 2010 to 2025
| NMDBFDelisted Stock | USD 0.50 0.00 0.00% |
Check NeonMind Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeonMind Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . NeonMind financial statements analysis is a perfect complement when working with NeonMind Biosciences Valuation or Volatility modules.
NeonMind |
NeonMind Biosciences Company Return On Equity Analysis
NeonMind Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current NeonMind Biosciences Return On Equity | -37.22 |
Most of NeonMind Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeonMind Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, NeonMind Biosciences has a Return On Equity of -37.2157. This is 55.26% higher than that of the Healthcare sector and 2.07% higher than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
NeonMind Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NeonMind Biosciences's current stock value. Our valuation model uses many indicators to compare NeonMind Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NeonMind Biosciences competition to find correlations between indicators driving NeonMind Biosciences's intrinsic value. More Info.NeonMind Biosciences is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NeonMind Biosciences' earnings, one of the primary drivers of an investment's value.About NeonMind Biosciences Financial Statements
NeonMind Biosciences stakeholders use historical fundamental indicators, such as NeonMind Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although NeonMind Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in NeonMind Biosciences' assets and liabilities are reflected in the revenues and expenses on NeonMind Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in NeonMind Biosciences. Please read more on our technical analysis and fundamental analysis pages.
NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp. Neonmind Biosciences is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in NeonMind Pink Sheet
If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets |